Table 2 Baseline characteristics of the patients in the included studies
Study ID | n (MSCs/placebo) | Male, n (MSCs/placebo) | Age, years (MSCs/placebo) | Protopathy | NHYA class (MSCs/Placebo) | Hypertension, n (MSCs/placebo) | Diabetes, n (MSCs/placebo) | BMI (MSCs/placebo) |
|---|---|---|---|---|---|---|---|---|
Wang JA | 12/12 | NA | NA | DCM | NA | NA | NA | NA |
Heldman AW | 19/11 | 18/10 | 57.1 ± 10.6/60.0 ± 12.0 | ICM | 2/2* | 12/6 | 3/3 | NA |
Zhao XF | 30/29 | 24/19 | 52.9 ± 16.32/53.21 ± 11.46 | DCM and ICM | NA | NA | NA | NA |
Mathiasen AB | 40/20 | 36/14 | 66.1 ± 7.7/64.2 ± 10.6 | ICM | 29/15* | NA | 15/3 | 29.8 ± 4.7/28.7 ± 5.3 |
Xiao W | 17/20 | 12/14 | 51.6 ± 12.2/54.4 ± 11.6 | DCM | NA | 4/7 | 5/6 | NA |
Butler J | 22 | 13 | 47.3 ± 12.8 | NICM | 1* | NA | 5 | NA |
Perin | 45/15 | 44/11 | 62.2 ± 10.3/62.7 ± 11.2 | DCM and ICM | 14/9* | 29/9 | 13/2 | 29.8 ± 4.1/31.3 ± 9.2 |
Bartolucci J | 15/15 | 12/14 | 57.33 ± 10.05/57.2 ± 11.64 | DCM and ICM | 2.03 ± 0.61/1.67 ± 0.49†| 7/8 | 5/7 | 29.12 ± 2.88/29.52 ± 4.0 |
Bartunek J | 120/151 | 107/136 | 61.6 ± 8.6/62.1 ± 8.7 | NA | 96/114* | NA | NA | 28.2 ± 3.7/28.6 ± 4.4 |